Rose Hips – Rosa Family
Swedish name: Nypon
Rose Hips (fruit), wild (Northern) nutrition facts and analysis per 100g
Nutrient | Amount | DV |
---|---|---|
Carbohydrate | 38.22 g | 13 % |
Fiber | 24.1 g | 96 % |
Sugars | 2.58 g |
Vitamins | ||
---|---|---|
Nutrient | Amount | DV |
Betaine | 2.9 mg | |
Choline | 12.0 mg | |
Folate | 3.00 mcg | |
Niacin | 1.300 mg | 8 % |
Pantothenic acid | 0.800 mg | 8 % |
Riboflavin | 0.166 mg | 10 % |
Thiamin | 0.016 mg | 1 % |
Vitamin A | 4345.00 IU | 87 % |
Vitamin A, RAE | 217.00 mcg | |
Carotene, alpha | 31.00 mcg | |
Carotene, beta | 2350.00 mcg | |
Cryptoxanthin, beta | 483.00 mcg | |
Lutein + zeaxanthin | 2001.00 mcg | |
Lycopene | 6800.00 mcg | |
Vitamin B6 | 0.076 mg | 4 % |
Vitamin C | 426.0 mg | 710 % |
Vitamin E | 5.84 mg | 19 % |
Tocopherol, alpha | 5.84 mg | |
Tocopherol, beta | 0.05 mg | |
Tocopherol, delta | 0.14 mg | |
Tocopherol, gamma | 1.34 mg | |
Tocotrienol, alpha | 0.01 mg | |
Tocotrienol, beta | 0.00 mg | |
Tocotrienol, delta | 0.00 mg | |
Tocotrienol, gamma | 0.07 mg | |
Vitamin K | 25.9 mcg | 32 % |
Minerals | ||
---|---|---|
Nutrient | Amount | DV |
Calcium, Ca | 169.00 mg | 17 % |
Copper, Cu | 0.113 mg | 6 % |
Iron, Fe | 1.06 mg | 6 % |
Magnesium, Mg | 69.00 mg | 17 % |
Manganese, Mn | 1.020 mg | 51 % |
Phosphorus, P | 61.00 mg | 6 % |
Potassium, K | 429.00 mg | 9 % |
Sodium, Na | 4.00 mg | 0 % |
Zinc, Zn | 0.25 mg | 2 % |
Proteins and Aminoacids | ||
---|---|---|
Nutrient | Amount | DV |
Protein | 1.60 g | 3 % |
STUDIES:
The effectiveness of a standardized rose hip powder, containing seeds and shells of Rosa canina, on cell longevity, skin wrinkles, moisture, and elasticity.
School of Antiaging and Regenerative Medicine, Mae Fah University, Bangkok, Thailand
“In the double-blinded study, the rose hip group showed statistically significant improvements in crow’s-feet wrinkles (P<0.05), skin moisture (P<0.05), and elasticity (P<0.05) after 8 weeks of treatment. A similar improvement was observed for astaxanthin, with P-values 0.05, 0.001, and 0.05. Likewise, both groups expressed equal satisfaction with the results obtained in their self-assessment. The rose hippowder further resulted in increased cell longevity of erythrocyte cells during storage for 5 weeks in a blood bank.”
– https://www.ncbi.nlm.nih.gov/pubmed/26604725
***
Phytochemistry, Traditional Uses and Pharmacological Profile of Rose Hip: A Review.
Department of Traditional Pharmacy, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
“Ethno-medical uses of rose hip have been recorded in many countries since a long time. Approximately, 129 chemical compounds have been isolated and identified from rose hip. This fruit contains some major active components such as flavonoids, tannins, anthocyanin, phenolic compounds, fatty oil, organic acids and inorganic compounds. Scientific studies have suggested a wide range of pharmacological activities for rose hip including antioxidant, anti-inflammatory, anti-obesity, anti-cancer, hepatoprotective, nephroprotective, cardioprotective, antiaging, anti H. pylori, neuroprotective and antinociceptive activities. In particular, the rose hip powder and extract have been reported to exert therapeutic effects on arthritis.”
– https://www.ncbi.nlm.nih.gov/pubmed/30317989
***
Anti-prediabetic effect of rose hip (Rosa canina) extract in spontaneously diabetic Torii rats.
Division of Bioscience and Bioenvironmental Sciences, Faculty of Agriculture, Graduate School of Kyushu University, Fukuoka, Japan.
“Spontaneously diabetic Torii (SDT) rats were supplemented with hot-water extract of rose hip at a dose of 100 mg kg-1 body weight day-1 for 12 weeks. The results obtained showed that the supplementation of rose hip extract improved impaired glucose tolerance, promoted insulin secretion, preserved pancreatic beta-cell function and suppressed plasma advanced glycation end-products formation of methylglyoxal-derived hydroimidazolone (MG-H1) residue and Nϵ -carboxymethyl-lysine residues (e.g. MG-H1, control: 465.5 ± 43.8 versus rose hip: 59.1 ± 13.0 pmol mg protein-1 , P < 0.05) in SDT rats at the prediabetic stage (12-20 weeks old).”
– https://www.ncbi.nlm.nih.gov/pubmed/28182280